Qnexa FDA weight loss pill NOT recommended for approval by committee-July 15, 2010

Will Qnexa be recommended for approval by the FDA?

The FDA advisory committee which reviewed Endocrine and Metabolic medicines met on Thursday, July 15th to review QNEXA, a new weight loss medicine which combines phentermine and topiramate in a single pill. the committee was concerned about benefits versus risks and did NOT recommend that the medicine be approved.

Approval Date: 
Thu, 07/15/2010
Company: 
Vivus

Contact Us
 

Our Location

Office Hours
Monday:9:00 AM - 5:00 PM
Tuesday:9:00 AM - 5:00 PM
Wednesday:9:00 AM - 5:00 PM
Thursday:9:00 AM - 5:00 PM
Friday:9:00 AM - 5:00 PM
Saturday:Closed
Sunday:Closed